In Conversation

Viranchi Shah – Managing Director, Saga Lifesciences; President, IDMA

Viranchi Shah – Managing Director, Saga Lifesciences; President, IDMA

India's thriving ecosystem, coupled with the increasing demand for the right partners and investments, makes it an ideal destination for those looking to be part of a journey marked by growth and innovation
Monica Bettencourt-Dias – Principal Investigator & Former Director, Gulbenkian Institute for Science (IGC)

Monica Bettencourt-Dias – Principal Investigator & Former Director, Gulbenkian Institute for Science (IGC)

The funding landscape for science in Portugal is facing challenges that stem from a decrease in overall investment and shifting priorities. Despite the evident role of blue-sky research, exemplified by important contributions to critical advancements like RNA vaccines, there has not been a corresponding increase in funding
Aris Mitsopoulos – Vice President, RAFARM

Aris Mitsopoulos – Vice President, RAFARM

Our country has the potential to emerge as a manufacturing and research hub for the wider region of Southeastern Europe
Alex Zhavoronkov – Founder & CEO, Insilico Medicine

Alex Zhavoronkov – Founder & CEO, Insilico Medicine

Thanks to generative AI we can double Big Pharma’s R&D productivity in a very small biotech setting
Maher Abouzeid – Managing Director, MedServe Medical Investment

Maher Abouzeid – Managing Director, MedServe Medical Investment

If you believe in the potential of this region, now is the time to invest, engage closely with stakeholders, and become an integral part of its growth story
Hocine Mahdi – Senior Director/GM, North, East & West Africa, IQVIA

Hocine Mahdi – Senior Director/GM, North, East & West Africa, IQVIA

Multinational companies will need to present robust dossiers explaining why the government should invest a certain amount of money in their products.
Hubert Mechin – President, AFCROs

Hubert Mechin – President, AFCROs

Leveraging this resource [the Systeme National des Donnees de Sante (SNDS)], we conduct numerous real-world studies, positioning France among the leaders in real-world evidence generation within Europe  
Sarah Aiosa – SVP & President, MSD Latin America

Sarah Aiosa – SVP & President, MSD Latin America

Two LatAm countries – Colombia and Mexico – are [MSD's] top clinical trial patient enrollers worldwide, and LatAm makes up approximately 15 percent of our total active trials
Mohamed Galal – Vice President & Head of Middle East/Pakistan Cluster, Bayer Consumer Health

Mohamed Galal – Vice President & Head of Middle East/Pakistan Cluster, Bayer Consumer Health

Whatever we dream here can be achieved. Dubai inspires us to grow and develop without limit
See more

In Case You Missed It

InFigures

Belgium, with a total of EUR 5.5 billion in R&D spending in 2021, is the country with the fourth largest research expenditure in the EU and the first per inhabitant.  As a recent study from Deloitte sponsored by the Belgian pharmaceutical industry association, pharma.be, shows, Belgium is also a leader in clinical trials, maintaining its…

The subject of intense industry criticism from the likes of lobby groups, Big Pharma, and biotech alike, the Inflation Reduction Act (IRA) subjects certain drugs to price negotiations directly with industry sponsors in the US for the first time. Ten initial drugs – which accounted for over USD 45 billion in Medicare Part D spending…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here